Aims The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary
intervention (PCI) in patients at high bleeding risk (HBR) is still debated. The current study …

Interest in the pathophysiology, etiology, management, and outcomes of patients with
tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing …

Background Severe tricuspid regurgitation is a debilitating condition that is associated with
substantial morbidity and often with poor quality of life. Decreasing tricuspid regurgitation …

Background The benefit of complete revascularization in older patients (≥ 75 years of age)
with myocardial infarction and multivessel disease remains unclear. Methods In this …

Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …

Aims We aimed to evaluate the acute safety and effectiveness of mechanical thrombectomy
for intermediate-and high-risk PE in a large real-world population. Methods FLASH is a …

BACKGROUND: Intravascular imaging–guided percutaneous coronary intervention (PCI)
with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) showed …

Background Vitamin K antagonists are the only oral anticoagulants approved to prevent
valve thrombosis and valve-related thromboembolism in patients with mechanical heart …

Background Prior studies of therapeutic-dose anticoagulation in patients with COVID-19
have reported conflicting results. Objectives We sought to determine the safety and …

BACKGROUND: Although venoarterial extracorporeal membrane oxygenation (VA-ECMO)
is beneficial for the treatment of profound cardiogenic shock, peripheral VA-ECMO …